热门出版物 - 学术资源搜索

h5 指数:88
h5 中位数:123

h5 指数是指在过去整整 5 年中所发表文章的 h 指数。h 指在 2018-2022 年间发表的 h 篇文章每篇至少都被引用过 h 次的最大值。隐藏

出版物的 h5 中位数，是指出版物的 h5 指数所涵盖的所有文章获得的引用次数的中位值。隐藏

标题/作者	引用次数	年份
Applications of Fluorine in Medicinal Chemistry EP Gillis, KJ Eastman, MD Hill, DJ Donnelly, NA Meanwell Journal of Medicinal Chemistry 58 (21), 8315-8359	1210	2015
The Essential Medicinal Chemistry of Curcumin: Miniperspective KM Nelson, JL Dahlin, J Bisson, J Graham, GF Pauli, MA Walters Journal of Medicinal Chemistry 60 (5), 1620-1637	575	2017
Analysis of Past and Present Synthetic Methodologies on Medicinal Chemistry: Where Have All the New Reactions Gone? Miniperspective DG Brown, J Boström Journal of Medicinal Chemistry 59 (10), 4443-4458	452	2016
Anti-HIV Drug Discovery and Development: Current Innovations and Future Trends: Miniperspective P Zhan, C Pannecouque, E De Clercq, X Liu Journal of Medicinal Chemistry 59 (7), 2849-2878	440	2016
Role of Molecular Dynamics and Related Methods in Drug Discovery M De Vivo, M Masetti, G Bottegoni, A Cavalli Journal of Medicinal Chemistry 59 (9), 4035-4061	351	2016
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design NA Meanwell Journal of Medicinal Chemistry 61 (14), 5822-5880	337	2018
pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures DEV Pires, TL Blundell, DB Ascher Journal of Medicinal Chemistry 58 (9), 4066-4072	334	2015
Structure-Based Optimization of Thiophene [3, 2-d] pyrimidine Derivatives as Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Improved Potency against Resistance-Associated Variants D Kang, Z Fang, B Huang, X Lu, H Zhang, H Xu, Z Huo, Z Zhou, Z Yu, ... Journal of Medicinal Chemistry 60 (10), 4424-4443	313	2017
Small-Molecule Inhibitors of the MDM2–p53 Protein–Protein Interaction (MDM2 Inhibitors) in Clinical Trials for Cancer Treatment: Miniperspective Y Zhao, A Aguilar, D Bernard, S Wang Journal of Medicinal Chemistry 58 (3), 1038-1052	313	2015
A Survey of the Role of Noncovalent Sulfur Interactions in Drug Design BR Beno, KS Yeung, MD Bartberger, LD Pennington, NA Meanwell Journal of Medicinal Chemistry 58 (11), 4383-4438	309	2015
Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide J Lau, P Bloch, L Schäffer, I Pettersson, J Spetzler, J Kofoed, K Madsen, ... Journal of Medicinal Chemistry 58 (18), 7370-7380	299	2015
Organic Carbamates in Drug Design and Medicinal Chemistry AK Ghosh, M Brindisi Journal of Medicinal Chemistry 58 (7), 2895-2940	266	2015
Quadruplex Nucleic Acids as Novel Therapeutic Targets S Neidle Journal of Medicinal Chemistry 59 (13), 5987-6011	256	2016
CNS Drug Design: Balancing Physicochemical Properties for Optimal Brain Exposure Z Rankovic Journal of Medicinal Chemistry 58 (6), 2584-2608	250	2015
The Current State of Peptide Drug Discovery: Back to the Future? A Henninot, JC Collins, JM Nuss Journal of Medicinal Chemistry 61 (4), 1382-1414	247	2018
The “Cyclopropyl Fragment” is a Versatile Player that Frequently Appears in Preclinical/Clinical Drug Molecules TT Talele Journal of Medicinal Chemistry 59 (19), 8712-8756	238	2016
An Aggregation Advisor for Ligand Discovery JJ Irwin, D Duan, H Torosyan, AK Doak, KT Ziebart, T Sterling, ... Journal of Medicinal Chemistry 58 (17), 7076-7087	221	2015
Discovery of a Cyclic Boronic Acid β-Lactamase Inhibitor (RPX7009) with Utility vs Class A Serine Carbapenemases SJ Hecker, KR Reddy, M Totrov, GC Hirst, O Lomovskaya, DC Griffith, ... Journal of Medicinal Chemistry 58 (9), 3682-3692	205	2015
Voltage-Gated Sodium Channels: Structure, Function, Pharmacology, and Clinical Indications M de Lera Ruiz, RL Kraus Journal of Medicinal Chemistry 58 (18), 7093-7118	188	2015
PAINS in the Assay: Chemical Mechanisms of Assay Interference and Promiscuous Enzymatic Inhibition Observed during a Sulfhydryl-Scavenging HTS JL Dahlin, JWM Nissink, JM Strasser, S Francis, LA Higgins, H Zhou, ... Journal of Medicinal Chemistry 58 (5), 2091-2113	183	2015

1 - 20

计算机程序会自动估算并确定日期和引用次数。